Release Summary

Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) collaborates with Imperial College London, providing funding for LeoPARDS Trial (Levosimendan for the Prevention of Acute oRgan Dysfunction in Sepsis).

Oxygen Biotherapeutics, Inc.